Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | BI-2536 | FIMM | pan-cancer | AAC | 0.054 | 0.7 |
mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | 0.029 | 0.7 |
mRNA | AT13387 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | BRD-K13999467 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | I-BET-762 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.019 | 0.7 |